Corrigendum to “Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer” [Eur J Cancer 180 (2023) 184–185]
The authors regret that an error was made in the detail for affiliation c. The correct affiliation is: Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Source: European Journal of Cancer - Category: Cancer & Oncology Authors: Fan Yang, Guanmo Liu, Feng Mao, Yong-Chang Zheng Tags: Corrigendum Source Type: research
More News: Academies | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | China Health | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy